Published on 24 May 2026
Categories:
Pharmaceutical Market Europe33 articles from this collection:
PME May 2026
2 COMMUNIQUE Awards
3 Comment
4 - PME Advert
5 Contents
6 News
Roche and Ascidian agree to $1.8bn neurological disease partnership
7 News
8 News
Researchers identify new major cause of inflammatory bowel disease
9 News
10 DERMATOLOGY NEWS
11 DERMATOLOGY NEWS
12 Brian D Smith Darwin’s Medicine - THE HUBS AND THE SPOKES
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
13 Mike Dixon PARTNERSHIP HEALTH
14 CHOOSING WHERE TO PLAY IN ONCOLOGY WITH FUTURE WORLDS
15 THE SHOP WINDOW, THE MESSY MIDDLE AND THE HONESTY MIRROR
Men’s health: the gap between awareness and action is where men’s lives are lost
18-20 The next frontier in clinical trials: navigating multi disease research with GLP-1s
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
21 Thought Leader - Remedy Edge
22-23 Obesity care in the UK – why it can’t improve until it is recognised as a disease
24-25 Bridging the gap between European brain innovation and real-world policy
26 Thought Leader - Valuebase
27 MARKETING & COMMS
28-29 Headline trade and market deals are opening doors to greater patient access
30 Thought Leader - Accession
Picking your omnichannel direction requires a disciplined, scientific approach
31 AD PAGE
32 - Lab News
33 Communique Intro
34-35 Communique
36 Communique
37 Communique
38 Communique
39 PMPS
40 FlyPharma
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services